NCT00891709View on ClinicalTrials.gov

LEO 29102 Single and Multiple Dose Study by Dermal Application

PHASE1CompletedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Atopic Dermatitis

Interventions

DRUG

LEO 29102

First-in-man. Healthy volunteers

Trial Locations (1)

CB23 2TN

LCG Bioscience, Bourn

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY